RobertLScottMDPhD, FACC

PubMed

• Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities.
  Moaz A Kamel, Isabel G Scalia, Amro T Badr, Nima Baba Ali, Juan M Farina
  Journal of Cardiovascular Development and Disease. 2024-03-21
• 1 citations
  Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
  Ahmed K Mahmoud, Mohammed Tiseer Abbas, Moaz A Kamel, Juan M Farina, Milagros Pereyra
  Journal of Personalized Medicine. 2023-12-20
• 6 citations
  Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center S...
  Rabea Asleh, Darko Vucicevic, Tanya M Petterson, Walter K Kremers, Naveen L Pereira
  Journal of Clinical Medicine. 2022-01-10

Journal Articles

• Is all intimal proliferation created equal in cardiac allograft vasculopathy?  
  Mehra MR, Ventura HO, Uber PA, Scott RL, Park MH, The Quantity-Quality Paradox J Heart Lung Transplant, 1/1/2003
• Difficult cases in heart failure: sildenafil and assessment of pulmonary arterial reactivity in heart failure  
  Alaeddini J, Uber P, Park MH, Scott RL, Mehra MR, Congest Heart Fail, 1/1/2003
• Is heart failure in African Americans a distinct entity?  
  Scott RL, Congest Heart Fail, 1/1/2003
• Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection  
  Park MH, Scott RL, Uber PA, Mehra MR, J Heart & Lung Transplant, 1/1/2002
• Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival  
  Mehra MR, Uber PA, Vivekananthan K, Solis S, Scott RL, Park MH, Milani RV, Lavie CJ, J Am Coll Card, 1/1/2002
• Native mitral valve regurgitation Proactive management can improve outlook  
  Scott RL, Postgrad Med, 1/1/2001
• Utility of heart biopsy in transplant patients  
  Beckman EN, Mehra MR, Park MH, Scott RL, The Ochsner Journal, 1/1/2001
• Choosing beta-blockers in systolic failure  
  Scott RL, The Ochsner Journal, 1/1/2000
• Join now to see all

Abstracts/Posters

• A novel human leukocyte antigen score improves prediction for rejection after heart transplant.
  Kransdorf EP, Gragert L, Cheng M, Steidley DE, Scott RL, Pando MJ, Maiers M, Pajaro OE, J Heart Lung Transplant, 1/1/2015
• Cardiac resynchronization therapy does not reduce ventricular arrhythmias after left ventricular assist device implantation.
  Schleifer JW, Mookadam F, Kransdorf E, Nanda U, Cha S, Pajaro OE, Steidley DE, Scott RL, Adams JC, Saadiq R, Carvajal TC, Srivathsan K, J Heart Lung Transplant, 1/1/2015
• Sirolimus based immunosuppression results in lower incidence of post-transplantation lymphoproliferative disorders in heart transplant recipients.
  Vucicevic D, Daly RC, Steidley DE, Scott RL, Kremers WK, Edwards BS, Sudhir KS, J Heart Lung Transplant, 1/1/2015
• Does antibody induction immunotherapy prevent the development of cardiac allograft vasculopathy?
  Kransdorf E, Cheng M, Steidley D, Scott R, Pajaro O, Transplantation, 1/15/2014
• Seroprevalence and risk factors associated with hepatitis e virus in heart and kidney transplant candidates.
  Unzueta A, Valdez R, Chang Y, Desmarteau Y, Heilman R, Scott R, Douglas D, Rakela J, Transplantation, 1/15/2014
• A novel allele-based measure of hla mismatch predicts treated rejection after heart transplant.
  Kransdorf EP, Carvajal T, Cheng M, Steidley DE, Scott RL, Leis JF, Adams RH, Bordner A, Balan V, Pajaro OE, J Heart Lung Transplant, 1/1/2014
• Effect of match for ethnicity on immunologic events after heart transplantation: an analysis of the unos/optn database.
  Carvajal T, Kransdorf EP, Cheng M, Steidley DE, Scott RL, Bordner A, Balan V, Pajaro OE, J Heart Lung Transplant, 1/1/2014
• Does antibody induction immunotherapy prevent the development of cardiac allograft vasculopathy?
  Kransdorf E, Cheng M, Steidley D, Scott R, Pajaro O, Am J Transplant, 1/1/2014
• Seroprevalence and risk factors associated with hepatitis e virus in heart and kidney transplant candidates.
  Unzueta A, Valdez R, Chang Y, Desmarteau Y, Heilman R, Scott R, Douglas D, Rakela J, Am J Transplant, 1/1/2014
• Cardiopulmonary exercise testing for cardiac risk assessment prior to kidney transplantation.
  Chakkera H, Roy S, Steidley E, Kalya A, Gopalan, Reddy K, Mulligan D, Heilman R, Hewitt W, Khamash H, Huskey J, Moss A, Katariya N, Scott R, Am J Transplant, 1/1/2013
• Human leukocyte antigen mismatch in heart transplants continues to predict outcomes in modern era of immunosuppression.
  Carvajal T, Kransdorf EP, Kasper DL, Scott RL, Steidley DE, Gopalan RS, Kalya AV, Arabia FA, Pajaro OE, J Heart Lung Transplant, 1/1/2013
• Survival to transplant in patients undergoing mechanical circulatory support as bridge: retrospective analysis of LVAD, BiVAD and TAH strategy.
  Pajaro OE, Kalya AV, Gopalan RS, Staley LL, Diane KL, Spadafore JM, Pierce CN, Noble BN, Krishnaswamy C, Scott RL, Arabia FA, J Heart Lung Transplant, 1/1/2012
• Comprehensive echo-doppler evaluation of syncardia total artificial heart (tah).
  Chandrasekaran K, Pierce CN, Gopalan RS, Pandit A, Scott RL, Kalya AV, Pajaro OE, Wong RK, Arabia FA, J Heart Lung Transplant, 1/1/2012
• Renal dysfunction following syncardia total artificial heart implantation does not affect survival following heart transplantation.
  Kalya A, Boyle K, Goel R, Arabia F, Pajaro O, Scott R, Gopalan R, Jaroszewski D, Kasper D, Wu Q, Staley L, Pierce C, J Heart Lung Transplant, 1/1/2012
• Utility of cardiopulmonary exercise testing for preoperative risk assessment in chronic kidney disease patients referred for orthotopic kidney transplantation.
  Scott RL, Chakkera HA, Steidley DE, Gopalan RS, Kalya AV, Thompson PL, Am J Transplant, 1/1/2012
• Efficacy of genetic profile testing using allomap (R) in combined heart-kidney transplant recipients.
  Scott RL, Kasper DL, Arabia FA, Gopalan RS, Bachtel CS, Jaroszewski DE, Attig SM, Lanza LA, DeValeria PA, Steidley E, J Card Fail, 1/1/2012
• Impact of syncardia total artificial heart on renal function in patients bridged to heart transplant.
  Kalya A, Goel R, Boyle K, Arabia F, DeValeria P, Jaroszewski D, Scott R, Steidley E, Gopalan R, Chakkera H, Mookadam F, Am J Transplant, 1/1/2011
• Safe and cost effective utilization of standard telemetry units for patients with right heart catheterization monitoring: a single center 5 year experience.
  Scott RL, Steidley DE, Gopalan RS, Kalya AV, Hess GM, Shatillo SG, Delgado DJ, J Heart Lung Transplant, 1/1/2011
• Use of luminex antibody testing and virtual crossmatching to enhance donor heart availability for sensitized heart transplant candidates: a single center experience.
  Scott RL, Kasper DL, Valdez R, Arabia FA, Bachtel CS, DeValeria PA, Steidley DE, Lanza LA, Jaroszewski DE, Gopalan RS, Kalya AV, Stoll ST, Pajaro OE, Attig SM, J Card Fail, 1/1/2011
• Efficacy of Ambrisentan in Treatment of Porto-Pulmonary Hypertension in Patients with End-Stage Liver Disease.
  Robert L. Scott, MD, International Society of Heart and Liver Transplantation, Chicago, IL, 1/1/2010
• The Use of Peripheral Gene Expression Testing in the Detection of Coronary Allograft Vasculopathy with Intravascular Ultrasound.
  Robert L. Scott, MD, International Society of Heart and Liver Transplantation, Chicago, IL, 1/1/2010
• The Use of Peripheral Gene Expression Testing in the Detection of Coronary Allograft Vasculopathy with Intravascular Ultrasound.
  Robert L. Scott, MD, American Transplant Congress, San Diego, CA, 1/1/2010
• Use of peripheral gene expression testing in the detection of coronary allograft vasculopathy with intravascular ultrasound.
  Scott RL, Kasper DL, Bachtel C, Fortuin FD, Sweeney JP, Lee RW, Steidley DE, Arabia FA, Gopalan RS, Kalya AV, J Heart Lung Transplant, 1/1/2010
• The SWAT team approach for treating the unstable patient in acute cardiopulmonary shock.
  Jaroszewski D, Pierce C, Scott R, Steidley E, Gopalan R, DeValeria P, Lanza L, Francisco A, J Heart Lung Transplant, 1/1/2010
• Efficacy of ambrisentan in treatment of porto-pulmonary hypertension in patients with end-stage liver disease.
  Scott RL, Steidley DE, Gopalan RS, Kalya AV, Wenzel AM, Marchi M, Aqel BA, Am J Transplant, 1/1/2010
• Join now to see all

Lectures

• Heart Failure Management: Putting Guidelines Into Practice. 
  Sedona, AZ - 1/1/2010
• Nightmare Cases in Heart Failure: How We Dealt with Them. 
  Sedona, AZ - 1/1/2010
• Heart Failure in 2010: What the Guidelines Say, What is Missing and What Should be Banned. 
  Sedona, AZ - 1/1/2010
• "Heart Disease in African Americans: Knowledge is Power" 
  Washington, DC - 1/1/2010
• "Heart Failure Management: Putting Guidelines Into Practice" 
  Scottsdale, AZ - 1/1/2010
• "Pulmonary Hypertension 2010: Optimizing Patient Outcomes" 
  Las Vegas, NV - 1/1/2010
• "Heart Failure: What's New for You - ACCF/AHA 2009 Focused Update Guideline for Diagnosis & Treatment of Heart Failure in Adults" (Keynote Lecture) 
  Tempe, AZ - 1/1/2010
• "BNP in Heart Failure" 
  Scottsdale, AZ - 1/1/2009
• Pulmonary Hypertension: What Information From Echo Laboratory Must be Provided for Assessment and Management. 
  Scottsdale, AZ - 1/1/2009
• Myocardial Function/Heart Failure-Basic/Molecular; Myocardial Function/Heart Failure-Clinical Pharmacological Treatment. 
  Orlando, FL - 1/1/2009
• Who Should Manage End of Life Care? 
  Orlando, FL - 1/1/2009
• "New Frontiers in the Treatment of Heart Failure" 
  Orlando, FL - 1/1/2009
• Acute Cardiogenic Shock: Which Drugs and Which Devices? 
  Orlando, FL - 1/1/2009
• "CHF Management" 
  Scottsdale, AZ - 1/1/2009
• Anything but a Biopsy: Detecting Rejection in the Thoracic Transplant Patient. 
  Las Vegas, NV - 1/1/2009
• Pneumatosis Intestinalis in Heart Transplantation. 
  Boston, MA - 1/1/2009
• Chronic Heart Failure Management: Putting Guidelines Into Practice. 
  Sedona, AZ - 1/1/2009
• Mechanical Circulatory Support for Advanced Heart Failure Bridge and Beyond. 
  Orlando, FL - 1/1/2009
• "Medical Therapy for Heart Failure: State of the Art 2008" 
  Phoenix, AZ - 1/1/2008
• The Critical Right Ventricular Chamber in Pulmonary Hypertension. 
  Toronto, Ontario, Canada - 1/1/2008
• "Optimal Medical Treatment of Pulmonary Hypertension in 2008" 
  Sedona, AZ - 1/1/2008
• CPX Training Program-Practicum in Exercise Testing and Interpretation. 
  UCLA Medical Center, Torrance, CA - 1/1/2008
• Pulmonary Hypertension: Classification, Prevalence and Treatment. 
  Phoenix, AZ - 1/1/2008
• "Heart Failure with Normal Systolic Function" 
  Phoenix, AZ - 1/1/2008
• Understanding Heart Failure and Heart Transplantation. 
  Scottsdale, AZ - 1/1/2008
• Join now to see all

Other

• Selenium and atherosclerosis. 
  Scott RL, Meharry Medical College Nutrition Center Newsletter
  1/1/1989